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ABSTRACT
Objectives: One part of the ultrasound examination of fetuses in the first trimester of gestation is visualization of the 
nasal bones. Numerous studies have demonstrated a correlation between the absence of nasal bones and  abnormal fetal 
karyotype. Aim: To assess the utility of ultrasound visualization of nasal bones during the first trimester of pregnancy as 
a marker of the most common chromosomal trisomies.
Material and methods: Ultrasound visualization of nasal bones was carried out  in 941 fetuses from a high-risk group 
between 11 + 0 and 13 + 6 weeks of gestation. Amniocentesis was performed to determine karyotype in all 941 cases.
Results: Normal fetal karyotype was observed in 847 cases, trisomy 21 in 45 cases, trisomy 18 in 16 cases and trisomy 13 in 10 cases.  
Other abnormal karyotypes were detected in the remaining 23 cases. The absence of nasal bones demonstrated 27% 
sensitivity, 97% specificity and a positive predictive value of 35% as an indicator of trisomy 21 in the study group, and 12% 
sensitivity, 97% specificity and 12% positive predictive value for trisomies 18 and 13.
Conclusions: The absence of nasal bones in ultrasound examination in the first trimester of pregnancy is characterized by 
low sensitivity and high specificity as a marker of the most common trisomies. Visualization of fetal nasal bone is a poor 
marker of aneuploidy and should not be taken into account in risk calculation algorithms.
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INTRODUCTION
Visualization of the nasal bones is one of the main stages 
of the fetal ultrasound examination between 11 + 0 and 
13 + 6 weeks of pregnancy. Numerous studies have reported 
a correlation between the absence of nasal bone in the first 
trimester of pregnancy and abnormal fetal karyotype. This 
has been attributed to the nasal bone ossification process 
being delayed in fetuses with chromosomal aberrations 
such as trisomies 21, 18 or 13.
In 1866, Langdon Down observed that patients with tri-
somy 21, the most commonly occurring chromosomal ab-
erration, were characterized by a typical facial appearance 
including a small, short nose [1]. In terms of frequency, Down’s 
syndrome is followed by Edwards syndrome, i.e. trisomy 18, 
with an incidence rate of up to 1/6,000 live births [2]. Follow-
ing this, trisomy 13 (Patau syndrome) is observed in 1/8,000 to 
1/12,000 live births. Trisomies 18 and 13 are characterized 
by a much more severe clinical presentation than Down’s 
syndrome, with less than 10% of children surviving the first 
year [3]. These trisomies are associated with the presentation 
of an abnormal profile together with multiple other serious 
defects [4]. It has been found that ultrasound scans performed 
between 11 + 0 and 13 + 6 weeks of gestation indicate an ab-
sence of nasal bones in more than 50% of fetuses with trisomy 
18, as well as in about 30% of fetuses with trisomy 13 [5].
Aim
To assess the value of ultrasound visualization of nasal 
bones during the first trimester of pregnancy as a marker 
of the most common chromosomal trisomies.
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MATERIAL AND METHODS
Nasal bone visualization was performed in 941 fetuses 
between 11 + 0 and 13 + 6 weeks of gestation (ultrasound 
scan + biochemical markers: PAPP-A + free βhCG) by certi-
fied researchers at two independent referral centers. Voluson 
E8 and Philips iU22 ultrasound scanners and transabdominal 
probes were used for the examination. The procedure was 
performed according to the Fetal Medicine Foundation 
standards of assessing the presence of nasal bones.
The presence of nasal bones was recorded in ultrasound 
scan summaries. The risk of fetal chromosomal aberrations 
was calculated on the basis of maternal age, ultrasound 
parameters (crown-lump length CRL, nuchal translucency 
NT) and biochemical analyses ( PAPP-A, free βhCG) using 
Astraia software.
Following the combined non-invasive first trimester 
screening, comprising ultrasound and biochemical test-
ing, an invasive diagnostic procedure was performed in all 
941 cases to assess fetal karyotype and identify any high 
risk of fetal aneuploidies.
RESULTS
In total, 941 fetal karyotype results were analyzed. 
A normal fetal karyotype was observed in 847 cases. Of the 
remainder, trisomy 21 was observed in 45 cases, trisomy 
18 in 16 cases, trisomy 13 in 10 cases, and other karyotype 
anomalies in the remaining 23 cases.
The nasal bones were observed to be absent in 39 fe-
tuses, including 22 with a normal karyotype; however, the 
nasal bones were visualized in 33 out of 45 T21 patients. In 
addition, they were observed in all fetuses with trisomy 18, 
and in seven of ten fetuses with trisomy 13 (Tab. 1).
Two study groups were defined for the purposes of 
statistical analysis: the group of fetuses with T21 syndrome 
(n = 45) and the combined group of fetuses with T18 and 
T13 syndromes (n = 26). The control group consisted of 
847 fetuses with a normal karyotype. The frequencies of 
absence of nasal bones in the T21 group and the T18 and 
T13 group were compared with that of the control group.
In the group of T21 patients, the nasal bones were found 
to be absent in 12 cases (Tab. 2). The absence of nasal bones 
demonstrated 27% sensitivity and 97% specificity as a mark-
er of T21, with a positive predictive value of 35%.
In the combined group of T18 and T13 patients, nasal 
bones were found to be absent in only three cases (Tab. 3). 
Lack of nasal bones was found to offer the 12% sensitivity 
and 97% specificity in the detection of trisomies 18 and 13, 
with a positive predictive value of 12%.
DISCUSSION
Current non-invasive risk assessment of fetal chromo-
somal aberrations is based on maternal age, ultrasound 
markers (NT, FHR) and biochemistry (PAPP-A, free βhCG). This 
algorithm allows the detection of 85–90% of fetuses with tri-
somies 21, 18, or 13, with some publications recording a de-
tection rate of 90–95% [6–8]. More sophisticated algorithms 
incorporating additional markers such as the presence of 
nasal bones, analysis of ductus venous or tricuspid valve 
flow have been proposed to reduce the false positive rate 
(FPR); however, these are the subject of ongoing research.
Many reports have proposed the absence of nasal bones 
as a potential marker of fetal chromosomal defects.  Our pre-
sent results obtained by ultrasound examination of fetuses 
with Down’s syndrome support those of previous studies 
indicating that the absence of nasal bones may be a promis-
ing marker of fetal trisomy 21. This has been confirmed in 
many reports, including data from multicenter studies [9, 10]
A paper published in The Lancet in 2001 reported the 
absence of nasal bones in 43 out of 59 (73%) ultrasound scans 
in the first trimester of pregnancy; however, while the study 
also reports that nasal bones were found to be absent in only 
0.5% of examined fetuses with normal karyotype [9]. This figure 
was found to be 2.6% in the present study. Węgrzyn et al. [10] 
(2016) reported nasal bones to be absent in 64.8% of fetuses 
with trisomy 21, but only 4.3% of fetuses with normal karyo-
type. Similarly, a higher rate of absence was also confirmed 
among fetuses with trisomy 21 (70%) in studies conducted in 
Table 3. Absence of nasal bones in T18 and T13 fetuses (n = 26) 
compared to controls
Nasal bones 
present, NB +
Nasal bones 
absent, NB −
Normal karyotype 825 (97.4%) 22 (2.6%)
T18, T13 23 (88.5 %) 3 (11.5 %)
Table 1. Presence of nasal bones vs. fetal karyotype: results of the 
analysis
NB + NB −
Normal karyotype 825 22
T21 33 12
T18 16 0
T13 7 3
Other karyotypic anomaly 21 2
Total 902 39
Table 2. Presence of nasal bones in T21 fetuses (n = 45) and controls
Nasal bones 
present, NB+
Nasal bones 
absent, NB -
Normal karyotype 825 (97.4%) 22 (2.6%)
T21 33 (73%) 12 (27%)
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much smaller study groups [11], and elsewhere, absence was 
noted in 70% of Down’s syndrome fetuses scanned in the first 
trimester of pregnancy [12]. Interestingly, while the authors of 
the mentioned article reported the absence of nasal bones in 
80% of fetuses with trisomy 18, this was observed in only 11.5% 
of fetuses from the combined group of trisomy 18 or 13 cases 
identified in the present study: the vast majority (88.5%) of 
fetuses tested between 11 + 0 and 13 + 6 weeks of pregnan-
cy were found to possess nasal bones. In addition, another 
ultrasound study found nasal bones to be absent in 52.8% 
of fetuses with trisomy 18, 45% of fetuses with trisomy 13, 
and only 59.8 % of fetuses with trisomy 21 [13]. Sepulveda 
et al. [14] reported nasal bone hypoplasia in 53% of a group of 
53 fetuses with trisomy 18, while Wagner et al. [15] reported 
a lack of nasal bones in 60% of fetuses with trisomy 18 and 69% 
of fetuses with trisomy 13.
Our data on the absence of nasal bones in ultrasound 
examination acquired in T21 syndrome fetuses between 
11 + 0 and 13 + 6 weeks of pregnancy are similar to those ob-
tained by other authors. As an ultrasound marker of trisomy 21, 
ultrasound identification of a lack of nasal bones is charac-
terized by low sensitivity (27%) and high specificity (97%). 
Likewise, Sieroszewski et al. [16] found such an approach to be 
characterized by low sensitivity (40%) but very high specificity 
(100%) in assessing the risk of chromosomal aneuploidies.
Our present findings indicate a much lower percentage 
of fetuses presenting an absence of nasal bones among the 
combined group of fetuses with less common aberrations, i.e. 
those with trisomies 13 or 18; in addition, the presence of nasal 
bones was detected in all fetuses with trisomy 18. The sensitiv-
ity and specificity of the absence of nasal bones as a predictive 
factor of these trisomies were 12% and 97%, respectively.
CONCLUSIONS
1. The absence of nasal bones between 11 + 0 and 
13 + 6 weeks of gestation, identified by ultrasound ex-
amination, can be used as a marker of the most common 
trisomies with low sensitivity and high specificity.
2. Visualization of the fetal nasal bone is a poor marker of 
aneuploidy and should not be taken into account in risk 
calculation algorithms.
REFERENCES
1. Langdon Do. Observations on an ethnic classification of idiots. Clinical 
Lectures and Reports, London Hospital. 1866; 3: 259–262.
2. Cereda A, Carey JC. The trisomy 18 syndrome. Orphanet J Rare Dis. 2012; 
7: 81, doi: 10.1186/1750-1172-7-81, indexed in Pubmed: 23088440.
3. Rasmussen SA, Wong LYC, Yang Q, et al. Population-based analyses of 
mortality in trisomy 13 and trisomy 18. Pediatrics. 2003; 111(4 Pt 1): 
777–784, doi: 10.1542/peds.111.4.777, indexed in Pubmed: 12671111.
4. Bruns DA, Campbell E. Nine children over the age of one year with full 
trisomy 13: a case series describing medical conditions. Am J Med Genet 
A. 2014; 164A(12): 2987–2995, doi: 10.1002/ajmg.a.36689, indexed in 
Pubmed: 25323598.
5. Nicolaides KH. Nuchal translucency and other first-trimester sonographic 
markers of chromosomal abnormalities. Am J Obstet Gynecol. 2004; 
191(1): 45–67, doi: 10.1016/j.ajog.2004.03.090, indexed in Pubmed: 
15295343.
6. Kagan KO, Etchegaray A, Zhou Y, et al. Prospective validation of 
first-trimester combined screening for trisomy 21. Ultrasound Obstet 
Gynecol. 2009; 34(1): 14–18, doi: 10.1002/uog.6412, indexed in Pub-
med: 19526452.
7. Kagan KO, Wright D, Maiz N, et al. Screening for trisomy 18 by maternal 
age, fetal nuchal translucency, free beta-human chorionic gonadotro-
pin and pregnancy-associated plasma protein-A. Ultrasound Obstet 
Gynecol. 2008; 32(4): 488–492, doi: 10.1002/uog.6123, indexed in 
Pubmed: 18726925.
8. Wright D, Syngelaki A, Bradbury I, et al. First-trimester screening for 
trisomies 21, 18 and 13 by ultrasound and biochemical testing. Fetal 
Diagn Ther. 2014; 35(2): 118–126, doi: 10.1159/000357430, indexed in 
Pubmed: 24356462.
9. Cicero S, Curcio P, Papageorghiou A, et al. Absence of nasal bone in fetus-
es with trisomy 21 at 11-14 weeks of gestation: an observational study. 
Lancet. 2001; 358(9294): 1665–1667, doi: 10.1016/S0140-6736(01)06709-
5, indexed in Pubmed: 11728540.
10. Węgrzyn P, Czuba B, Serafin D, et al. Nasal bone in screening for T21 at 11-
13 + 6 weeks of gestation - a multicenter study. Ginekol Pol. 2016; 87(11): 
751–754, doi: 10.5603/GP.2016.0082, indexed in Pubmed: 27958633.
11. Otaño L, Aiello H, Igarzábal L, et al. Association between first trimester 
absence of fetal nasal bone on ultrasound and Down syndrome. Prenat 
Diagn. 2002; 22(10): 930–932, doi: 10.1002/pd.431, indexed in Pubmed: 
12378580.
12. Zoppi MA, Ibba RM, Axiana C, et al. Absence of fetal nasal bone and ane-
uploidies at first-trimester nuchal translucency screening in unselected 
pregnancies. Prenat Diagn. 2003; 23(6): 496–500, doi: 10.1002/pd.628, 
indexed in Pubmed: 12813765.
13. Kagan KO, Cicero S, Staboulidou I, et al. Fetal nasal bone in screening for 
trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. 
Ultrasound Obstet Gynecol. 2009; 33(3): 259–264, doi: 10.1002/uog.6318, 
indexed in Pubmed: 19248005.
14. Sepulveda W, Wong AE, Dezerega V. First-trimester sonographic findings 
in trisomy 18: a review of 53 cases. Prenat Diagn. 2010; 30(3): 256–259, 
doi: 10.1002/pd.2462, indexed in Pubmed: 20112232.
15. Wagner P, Sonek J, Hoopmann M, et al. First-trimester screening for 
trisomies 18 and 13, triploidy and Turner syndrome by detailed early 
anomaly scan. Ultrasound Obstet Gynecol. 2016; 48(4): 446–451, doi: 
10.1002/uog.15829, indexed in Pubmed: 26611869.
16. Sieroszewski P, Baś-Budecka E, Perenc M. [Nasal bone (NB) length 
measurement in the first trimester of pregnancy in Polish population 
and its validity as fetal aneuploidy indicator]. Ginekol Pol. 2007; 78(8): 
616–620, indexed in Pubmed: 18050610.
